Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Stem Cell Transplantation in Elderly Patients”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT04469985
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

Who this might be right for
Allogeneic Stem Cell Transplantation in Elderly Patients
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Not applicableStudy completedNCT01095874
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study

Who this might be right for
Myelodysplasia
Saint-Louis Hospital, Paris, France 164
Not applicableStudy completedNCT04386928
What this trial is testing

ALLO-SCT in Elderly Patients With Hematological Disease

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 1,996
Testing effectiveness (Phase 2)Study completedNCT01404741
What this trial is testing

5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeChronic Myelomonocytic Leukemia
Universitätsklinikum Hamburg-Eppendorf 191
Testing effectiveness (Phase 2)UnknownNCT05583175
What this trial is testing

Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies

Who this might be right for
Leukemia, Myeloid, AcuteMDSHematopoietic Stem Cell Transplantation+1 more
Xianmin Song, MD 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06083129
What this trial is testing

Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

Who this might be right for
GVHD
Assistance Publique - Hôpitaux de Paris 324
Not applicableActive Not RecruitingNCT04914338
What this trial is testing

A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 40
Not applicableStudy completedNCT00723333
What this trial is testing

Bone Marrow Transplant Chart Review for RIC

Who this might be right for
Myelofibrosis
University of Utah 30
Large-scale testing (Phase 3)Looking for participantsNCT07396480
What this trial is testing

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Who this might be right for
VenentoclaxMyeloid MalignanciesConditioning+3 more
First Affiliated Hospital of Zhejiang University 186
Not applicableActive Not RecruitingNCT04375579
What this trial is testing

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplant
Assistance Publique - Hôpitaux de Paris 205
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Post-approval studies (Phase 4)UnknownNCT00199147
What this trial is testing

Efficacy of G-CSF-Priming in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
Johann Wolfgang Goethe University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00382759
What this trial is testing

Nonmyeloablative Stem Cell Transplant in Elderly

Who this might be right for
Hematological Malignancies
Azienda Ospedaliera San Giovanni Battista 50
Testing effectiveness (Phase 2)WithdrawnNCT02630836
What this trial is testing

Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture

Who this might be right for
Femoral Neck Fracture
Banc de Sang i Teixits
Not applicableActive Not RecruitingNCT04822766
What this trial is testing

A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 24
Early research (Phase 1)Looking for participantsNCT05849207
What this trial is testing

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Who this might be right for
Hematologic Malignancies
Ronald Paquette 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066255
What this trial is testing

PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

Who this might be right for
Hematological Malignancy
Institut Paoli-Calmettes 27
Large-scale testing (Phase 3)Study completedNCT02623309
What this trial is testing

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

Who this might be right for
Hematologic Neoplasms
Institut Paoli-Calmettes 108
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Load More Results